TRIOSE Names Gerry Romanelli Chief Commercial Officer

11/16/17

TRIOSE announced today the promotion of Gerry Romanelli to Chief Commercial Officer, and that Romanelli is now a managing owner of the corporation.

According to Carl "CJ" Joyner, Chief Executive Officer of TRIOSE, "Ira and I are thrilled to have Gerry serve in the role as Chief Commercial Officer, and furthermore, to join in as part of the ownership team." Joyner stated, "Since 2016, when Gerry joined the company, he has helped us continue to grow TRIOSE into the nation's premier healthcare solutions supply chain provider."

In his new role as Chief Commercial Officer, Romanelli will oversee marketing, sales, new product development and all aspects of continued revenue growth.

Ira Tauber, TRIOSE'S President, noted, "CJ and I couldn't be happier to have Gerry as a new executive owner and partner in TRIOSE. His energy, passion and commitment to our company continues to position TRIOSE as the healthcare supply chain solutions company both today and in the future."

Joyner and Tauber will continue to be major majority owners of TRIOSE.

About TRIOSE, Inc.

TRIOSE, Inc. is a national healthcare supply chain solutions company that delivers smart, total logistics solutions customized for each client's needs; lowers supply chain costs; and drives change for better healthcare in our communities. TRIOSE's SupplyLinQ, a healthcare data analytics engine, helps healthcare clients reduce supply cost, mitigate risk, and improve quality of care. TRIOSE's logistics portfolio solutions include freight management, large cargo freight, courier management and 3PL consulting.

Privately held since 1999, TRIOSE has been recognized by a number of awards from Philadelphia SmartCEO, Vizient NOVAPLUS® 2016 Supplier of the Year, and is among an elite 7% of companies to make Inc. 5000's fastest-growing companies for five consecutive years. Visit TRIOSE to learn about its innovative healthcare supply chain solutions.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.